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There is increasing evidence that Plasmodium falciparum malaria is influenced by 
ABO blood group but the extent of association between the two is yet to be well defined. 
This study was sought to determine if certain individuals are predisposed to P. falcipa-
rum malaria parasite infection by virtue of their ABO blood group, and the malaria 
parasitaemia prevalence rate among presumably healthy donors. A total of 437 blood 
samples were examined following best practices. Thick and thin blood films were made 
from each sample and ABO blood groups determined by a standard tube agglutination 
technique. Of the 437 samples examined, 13% had malaria parasite in their blood, all 
of which was identified as P. falcipurum. Most of the donors, 70.5% (308) were females, 
while 29.5% (129) were males. Of the 129 male donors, 19.4% had malaria parasites in 
their blood, while 10.4% of the 308 females had malaria parasites. The infection per-
centage was significantly higher in the males compared to the females. The respective 
infective rates were 14.3, 11.1, 13.9 and 0.00% for the blood groups A, B, O and AB. 
The difference in infection percentage between the various blood groups was, however, 
not statistically significant. The malaria prevalence rate of 13.0% among the donors in 
this study is an indication of asymptomatic parasitaemia among blood donors and thus 
poses a great risk to blood recipients. 
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Malaria is a very important disease in 
Sub-Saharan Africa with high morbidity and 
mortality rates (WHO 1994), which conse-
quently leads to a dwindle in the productivity 
of a nation (WHO 1994). The most common 
individuals at high risk of malaria infection in 
endemic areas are people of low immunity, for 
instance, foreigners, pregnant women, children 
(Weir and Stewart 1997) and perhaps 
HIV/AIDS patients (Migot et al. 1996; 
Chandramohan and Greenwood 1998). 
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Transfusion therapy is the use of blood 
and blood products as a form of treatment to 
save lives. However, this process can lead to 
transfusion transmitted infections such as ma-
laria parasites if blood is received from a ma-
laria infected donor (Okocha et al. 2005). An 
initial report on malaria as a result of blood 
transfusion has been published in 1911 (Wool-
sey 1911). Evidence shows that all the four 
human parasites of malaria, which are P. falci-
parum, P. malariae, P. vivax and P. Ovale, 
may possibly be transmitted through blood 
transfusion (Wylie 1993). Of outmost concern 
is that the majority of the individuals that re-
quire blood transfusion are often already desta-
bilised by one disease or the other and their 
immunity is already compromised. The malaria 
parasites behave violently in these individuals 
leading to very serious complications and even 
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death (Ali et al. 2004). It has also been evi-
denced that the human plasmodium parasite 
can continue to exist in stored and frozen blood 
(Talib and Khurana 1995), which makes ma-
laria transmission by blood transfusion even 
more dangerous and of greater concern. 
The WHO reports that, there are about 
300-500 million incidences of malaria causing 
2-3 million deaths each year in the tropical and 
subtropical regions of the world. About 90% of 
these deaths occur in Sub-Saharan Africa 
(WHO 2003). This could be as a result of P. 
falciparum which is the most dangerous of the 
four parasites being the main cause of infec-
tions in this region and also the main malaria 
transmitting vector (Anopheles gambiae) being 
spread widely and very difficult to control 
(WHO 2003). 
Regardless of the soaring malaria inci-
dence in endemic regions, a certain group of 
individuals seem to have more immunity to 
malaria than others. This could be accounted 
by several factors including haemoglobin vari-
ants, ABO blood group system and enzyme 
action, among others (Otajevwo 2013). An in-
vestigation into malaria in correlation with, for 
instance, ABO blood group has the potential of 
giving an insight into the pathogenesis of ma-
laria and perhaps aid the control of this disease. 
The link between ABO blood groups and 
the incidence of malaria parasitaemia or immu-
nity to malaria is still unclear (Akinboye and 
Ogunrinade 1987; Thakur and Verma 1992). 
This is probably because the relations between 
the blood group and malaria have not been well 
studied (Singh et al. 1995). Other studies have 
revealed that the formation of rosette which is 
triggered by malaria parasite is linked to the 
rigorousness of clinical disease (Rowe et al. 
1995) as well as cerebral malaria (Treutiger et 
al. 1992). Interestingly, some researchers have 
found that, these rosettes are formed better de-
pending on the blood cell types, with the blood 
cell type A and B having higher chances of 
forming rosettes (Carlson and Wahlgren 1992; 
Udomsangpetch et al. 1993). Other studies 
have also shown that blood types A, B and AB 
are more vulnerable to plasmodium falciparum 
malaria than the O blood type (Omotade et al. 
1999), whereas others have reported an equal 
vulnerability among the various ABO blood 
types (Otajevwo 2013). There is, therefore, no 
consensus yet, hence the need for more re-
search in this respect to help the understanding 
of malaria pathogenesis with regards to its as-
sociation with ABO blood type.  
This study was aimed at determining the 
prevalence of malaria parasitaemia among the 
blood donors at Komfo Anokye Teaching Hos-
pital in Ghana and also to investigate if certain 
individuals by virtue of their ABO blood type 
are predisposed to getting malaria. 
 
2. Materials and Methods 
 
2.1 Ethical Clearance 
This study was conducted at the blood 
bank of the Komfo Anokye Teaching Hospital 
(KATH), Kumasi, Ghana. The hospital serves 
as a referral centre for blood transfusion ser-
vices in the Ashanti region. The relevant ap-
proval for this study was obtained from the 
committee of human research publications and 
ethics at KATH and Kwame Nkrumah Univer-
sity of Science and Technology, Kumasi. 
 
2.2 Inclusion and Exclusion Criteria 
A total of 437 apparently healthy blood 
donors were considered for the study. Subjects 
were made up of males and females. The do-
nors included volunteer and replacement blood 
donors, with blood pressures between 90-
140/60-90 mmHg, body weight of 50 kg and 
above. Each donor was also screened for 
HbsAg, HCV, and HIV-antibodies. Their Hb 
values were not less than 12 g/dl or 13 g/dl for 
females and males, respectively. Excluded 
from the study were those taking drugs for high 
blood pressure, having Hb below the above, 
who have tested positive for HbsAg, HCV, or 
HIV-antibodies, who have had jaundice, liver 
disease, epilepsy, diabetes, duodenal or gastric 
ulcer, asthma and tuberculosis, or sickle cell 
disease. Prostitutes, homosexuals, drug addicts, 
those taking self-injected drugs, and those who 
weighed less than 50 kg were also excluded. 
 
2.3 Phlebotomy and Laboratory Analysis 
Blood samples were collected after 
swabbing the area to be sampled with 70% al-
cohol and air dried. Venous blood was col-
lected from the median cubital vein of the 
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study subjects using 5-ml capacity disposable 
syringes fitted with needles. The blood was 
dispensed into specimen containers containing 
pre-measured amount of dipotasium salt of 
ethylene diamine tetra acetic acid (EDTA). 
Gentle mixing of the EDTA and the blood was 
ensured and then thick and thin blood films 
were prepared from the venous blood contain-
ing EDTA. The films were stained for 30 min-
utes in 5% solution of Giemsa stain. Blood 
films were examined under ×100 objective lens 
(immersion oil) using a light microscope as 
described by the WHO method (WHO 1993). 
Parasite densities were calculated using 
the thick films by the WHO method (parasite 
count × 6,000 divided by the number of WBCs 
counted) (WHO 1993), and the thin films were 
used to establish the species and infective 
stages of the parasites. Films were classed as 
negative when no parasites were seen after two 
hundred microscopic fields were being exam-
ined. For purposes of quality control, slides 
were cross-examined independently by a senior 
biomedical scientist and the results compared. 
The patients’ various ABO blood groups were 
also determined by a standard tube agglutina-
tion technique (forward and reverse ABO 
blood grouping) (WHO 1993). 
 
2.4 Statistical Analysis 
The results are presented as Mean ± SD. 
All categorical variables were analysed using 
Chi-Square Test. Statistical analysis was per-
formed using GraphPad Prism software and 




The demographic characteristics of the 
donors screened in this study are summarized 
in Table 1. The mean age of the donors was 
17.8 ± 3.3 (mean ± SD) with a range of 15-50 
yrs. Most of the donors 70.5% (308) were fe-
males, while 29.5% (129) were males. The ma-
jority of the donors (90.6%) were aged 15-20, 
followed by 21-25 (6.2%) and then 1.6% for 
both 26-30 and >30 age groups. 
The prevalence of the various ABO 
blood groups were 20.82, 18.54, 57.44 and 
3.20% for Groups A, B, O and AB, respec-
tively. About 97.71% of the donors were rh D 
positive, while only 2.29% of them were rh D 
negative. 
The distribution of the various blood 
groups in relation to sex is summarized in 
Table 2. The majority of the donors among 
both males and females belonged to group O 
and there was no statistically significant 
difference in the occurrence of ABO blood 
group phenotype in males and females (P = 
0.3098). 
Of the 129 male donors examined, about 
19.4% had malaria parasites in their blood, 
while 10.7% of the 308 females had malaria 
parasites. The infection percentage was signifi-
cantly higher among the males compared to the 
females (P = 0.0199) as shown in Fig. 1. The 
odds of developing malaria infection among 
the males were 2.003 relative to the females 
(OR = 2.003; 95% CI = 1.137 to 3.530). All the 
malaria infections were identified as P. falcipu-
rum and of the 437 total samples examined, 57 
(13%) had malaria parasites in their blood. 
 
Table 1. Demographic characteristic of the 
study subjects. 











Rh factor  
Rh positive 427(97.70) 
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Table 2. Distribution of ABO blood groups by 
sex. 
Sex A B AB O 
Male 31 20 0 78 
Female 60 61 14 173 
 
 
Fig. 1. The prevalence of malaria parasitaemia 
among male and female donors. 
 
The prevalence of malaria parasites in 
blood donors according to age is shown in 
Table 3. The age group of 21-25 years recorded 
the highest prevalence rate (22%) and mean 
parasite density of 2,000 parasites/µl of blood, 
followed by the age group of >30 years of 14% 
prevalence rate and 2,000 mean parasite 
density. The age group of 15-20 years had a 
prevalence rate of 13% with the highest mean 
parasite density of 2,234.69/µl (Table 3). 
The respective infective rate and the mean 
parasite densities are 14.3% and 1307.69/µL, 
11.1% and 2,055.56/µL, 13.9% and 
2571.43/µL and 0.0 for blood groups A, B, O 
and AB as shown in Table 4. The difference in 
infection percentage between the various blood 
groups was, however, not statistically 
significant (
2
 = 5.528; P = 0.1370). 
 
Table 3. Prevalence of malaria parasites in 









15-20 396 13 22,234.69 
21-25 27 22 2,000.00 
26-30 7 0 0.00 
>30 7 14 2,000.00 
Table 4. Prevalence of Malaria parasitaemia 











A 91 14.3 1,307.69 
B 81 11.1 2,055.56 
AB 14 0.0 0.0 




Safe blood transfusion has been a key 
worry to health workers since the beginning of 
blood transfusion many years ago. The malaria 
prevalence rate of 13.0% among blood samples 
examined in this study, though not very high, 
still poses some concerns. In fact, these were 
donors that were presumed to be healthy and 
perhaps reflect the high endemicity of malaria 
in the country. The implication of this is that 
thirteen in one hundred blood donors bear the 
risk of passing on malaria parasites to their 
recipients. Unfortunately, the most common 
group of patients who need blood transfusion 
fall under the malaria vulnerable group (e.g. 
pregnant women, children under five years and 
the immunocompromised patients) (Qari et al. 
1993). If these groups of people are transfused 
with malaria infected blood, it could exacerbate 
their conditions. 
The prevalence rate in this study was, 
however, low compared to 40.9% by Uneke 
(2007) among donors in South-Eastern Nigeria, 
30.2% by Okocha et al. (2005) in Nnewi, 
Nigeria, and 51.5% by Epidi et al. (2008) 
among blood donors in Abakaliki in Nigeria. 
The low rate in the current study could be due 
to the difference in the study populations. 
It has been evidenced that in countries 
where blood donation is a commercial business 
deal, transfusion transmitted malaria is very 
common (Enosolease et al. 2004). 
The issue of commercial donors has not 
gained grounds in Ghana, and Kumasi in 
particular, where the majority of the donors are 
from the various senior high schools and blood 
donation clubs in the Kumasi metropolis, thus 
perhaps another reason for the comparatively 
low rate in this study. 
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The infection percentage was 
significantly higher in males than females, 
19.4% vs. 10.7% for males and females, 
respectively. The odds of developing malaria 
were about twice higher in males relative to 
females. The finding in this study is similar to 
the work of Bonilla and Rodriguez (1993), 
where males had a higher malaria parasite 
infection rate than females. The presents study 
was, however, in contrast to that of Vlassoff 
and Bonilla (1994) which reported more 
females being infected than males, and also 
that of Otajevwo (2013) which reported a 
higher infection rate in females than males. 
One interesting feature in this study was the 
fact that there were more female donors than 
males and this was encouraging because blood 
donation was originally seen as the preserve of 
the male gender in Ghana. The low rate of 
infection among female donors also goes to 
suggest that female students were less exposed 
to mosquitoes that transmit the P. falcipurm 
malaria parasite. 
Interestingly, in this study, the mean 
parasite densities decreased with an increase in 
age and although individuals aged between 15-
20 years had the highest density of 2,234.69/µl, 
individuals with age between 21-25 years had 
the highest infection rate of 22.0%. The reason 
for this difference observed in terms of age was 
not actually clear and needs further 
investigation. It was, however, clear that the 
majority of the infected individuals were the 
young adults and the adolescence. Since these 
groups of people are the principal blood donors 
(WHO 2003), there is therefore a strong need 
to intensify malaria control programs among 
these groups. 
The infection percentage rate in a 
decreasing order was as follows: blood group 
A, followed by O, then B, and AB being the 
least infected, even though the difference was 
not statistically significant. This findings is 
similar to the studies of Uneke (2007) in South-
Eastern Nigeria who found that there was no 
significant relationship between ABO blood 
groups and P. falciparum malaria, and also 
similar to the work of Otajevwo (2013) who 
found that any of the ABO blood groups were 
at equal chances of malaria infection. However, 
it contradicts the study of Singh et al. (1995) 
who reported that group B was the most 
vulnerable (41.8%), followed by group A 
(29%), then group O (22.2%), and group AB 




The malaria prevalence rate of 13.0% 
among the donors in this study is an indication 
of asymptomatic parasitaemia among blood 
donors and thus poses a great risk to blood re-
cipients, especially the malaria vulnerable 
groups.  
The findings of this study also did not 
support the assertion that individuals with cer-
tain blood groups were predisposed to Plasmo-
dium falciparum malaria infection. This im-
plies that there should not be any bias towards 
a particular ABO blood type in the manage-
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